Meeting
2020 Gastrointestinal Cancers Symposium
Economic burden and patterns of care in patients with advanced hepatocellular carcinoma.
Authors
Abdalla Aly
AstraZeneca, Gaithersburg, MD
Abdalla Aly , Elisabetta Malangone-Monaco , Virginia Noxon , Caroline Henriques , Fernando Benavente , Amy K. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 487)
Abstract #
487
Poster Bd #
A12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.
First Author: Stephen Chan
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Sorafenib plus tislelizumab as maintenance therapy for patients with advanced hepatocellular carcinoma treated with transarterial chemoembolization: A phase II study.
First Author: Mingyue Cai
Poster
2022 ASCO Annual Meeting
Efficacy and safety of low-dose apatinib in advanced hepatocellular carcinoma.
First Author: Lingbin Meng
Poster
2021 Gastrointestinal Cancers Symposium
Treatment patterns and survival in patients with late-stage hepatocellular carcinoma in France: A retrospective database analysis.
First Author: Jean-frederic Blanc